LOZZI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 16.088
EU - Europa 6.734
AS - Asia 3.826
SA - Sud America 653
AF - Africa 199
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 27.526
Nazione #
US - Stati Uniti d'America 15.981
CN - Cina 1.615
GB - Regno Unito 1.547
RU - Federazione Russa 1.319
SG - Singapore 1.039
IE - Irlanda 914
UA - Ucraina 626
SE - Svezia 572
BR - Brasile 530
DE - Germania 496
FR - Francia 402
IT - Italia 392
VN - Vietnam 327
HK - Hong Kong 277
FI - Finlandia 202
KR - Corea 202
ZA - Sudafrica 109
IN - India 97
ES - Italia 68
CA - Canada 52
AR - Argentina 47
BD - Bangladesh 41
BE - Belgio 34
NG - Nigeria 33
PL - Polonia 33
NL - Olanda 30
JP - Giappone 29
TR - Turchia 27
MX - Messico 26
IQ - Iraq 20
PK - Pakistan 20
CZ - Repubblica Ceca 18
RO - Romania 18
EC - Ecuador 17
AT - Austria 16
AU - Australia 16
IR - Iran 15
CI - Costa d'Avorio 14
JO - Giordania 14
VE - Venezuela 14
CO - Colombia 11
ID - Indonesia 11
PH - Filippine 11
PY - Paraguay 10
AZ - Azerbaigian 9
CL - Cile 9
IL - Israele 9
KE - Kenya 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
EU - Europa 8
MA - Marocco 8
NP - Nepal 8
TN - Tunisia 8
DZ - Algeria 6
KZ - Kazakistan 6
LB - Libano 6
LT - Lituania 6
PE - Perù 6
RS - Serbia 6
SA - Arabia Saudita 6
GR - Grecia 5
JM - Giamaica 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
UZ - Uzbekistan 5
BY - Bielorussia 4
UY - Uruguay 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KG - Kirghizistan 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
Totale 27.517
Città #
Dallas 8.000
Southend 1.370
Dublin 907
Fairfield 799
Ashburn 641
Menlo Park 608
Singapore 584
Chandler 582
Jacksonville 490
Woodbridge 432
Moscow 355
Santa Clara 355
Seattle 345
Beijing 344
Wilmington 342
Houston 334
Ann Arbor 290
Cambridge 278
Hong Kong 272
Hefei 243
San Jose 239
Seoul 201
Siena 197
Nanjing 177
Princeton 167
The Dalles 110
Los Angeles 108
Johannesburg 105
Ho Chi Minh City 103
New York 95
Helsinki 87
Shanghai 84
Fremont 83
Lauterbourg 79
Boardman 77
Munich 73
Hanoi 71
San Mateo 69
Nanchang 67
Buffalo 61
São Paulo 51
Málaga 50
San Diego 50
Dong Ket 45
Dearborn 43
Shenyang 39
Council Bluffs 37
Orem 37
Abuja 33
Brussels 31
Changsha 30
Tianjin 30
Hebei 29
Redwood City 28
Turku 28
London 26
Warsaw 26
Toronto 24
Jiaxing 23
Milan 23
Bengaluru 22
Chennai 22
Kunming 22
Zhengzhou 21
Chicago 20
Frankfurt am Main 20
Jinan 20
San Francisco 20
Tokyo 20
Amsterdam 18
Washington 18
Columbus 16
Florence 16
Belo Horizonte 15
Guangzhou 15
Rio de Janeiro 15
University Park 15
Abidjan 14
Brasília 14
Brooklyn 14
Amman 13
Lancaster 13
Redondo Beach 13
Atlanta 12
Brno 12
Kansas City 12
Ningbo 12
Timisoara 12
Boston 11
Denver 11
Rome 11
Stockholm 11
Dhaka 10
Hangzhou 10
Hải Dương 10
Izmir 10
Manchester 10
Norwalk 10
Nürnberg 10
Paris 10
Totale 21.087
Nome #
1 H‐ and natural abundance 15 N‐nmr studies of a derivative of a rabies glycoprotein fragment 7.476
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 376
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 364
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 353
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 337
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 325
A model of the rabies virus glycoprotein active site 315
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 312
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 310
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 301
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 287
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 286
Tumor imaging with tetrabranched neurotensin 268
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 264
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 260
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 259
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 253
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate camcer metastates, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2 251
Branched Neurotensin For Tumor Targeting 249
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 244
Bioactive peptides from libraries 243
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 243
Branched peptides as targeting agents for tumor imaging and therapy 240
Toxin-related antibodies with antimicrobial and antiviral activity 238
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 238
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 233
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 232
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 231
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 230
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 226
Highly fluorescent protein labeling using dendritic peptide derivatives 225
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 224
Synthetic peptides in the form of dendrimers become resistant to protease activity 220
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 218
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 218
Antigenicity of synthetic peptides derived from C100 protein of hepatitis C virus 217
Single step purification of a synthetic peptide fragment of neurofilaments by preparative high performance liquid-chromatography 214
Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins 214
CD and NMR structural characterization of ceratotoxins, natural peptides with antimicrobial activity 213
Dynein heavy chain related polypeptides in growing pollen tube of Nicotiana tabacum 213
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 210
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 210
The antimicrobial peptide M33. An example of drug development 209
Branched neurotensin for tumor targeting 206
Interaction of Angiotensin II with the C-terminal 300-320 fragment of the rat Angiotensin II Receptor AT1a monitored by NMR 204
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 204
Tumor selective targeting by branched peptides 202
Binding of HIV-1 gp120 to the nicotinic receptor 200
Synthetic peptides of rubella E1 glycoprotein for serological assays 198
Molecular basis of branched peptides resistance to enzyme proteolysis 198
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 197
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 196
High molecular weight polypeptides related to dynein heavy chains in Nicotiana tabacum pollen tubes 195
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 194
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 193
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 188
Micro-determination of amino acid composition of proteins electroblotted onto polyvinylidene difluoride membranes 186
Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides 185
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies 184
Surface Plasmon Resonance analysis of HIV-1 gp 120 binding to muscle nicotinic receptors 184
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 182
Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies 179
Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides 178
SNARE motif and neurotoxins 175
Epitopes identification by limited proteolysis 175
Synthetic antidotes against snake neurotoxins 175
Toxin-related antibodies with antimicrobial and antiviral activity 174
Selection of catalytically active biotin ligase and trypsin mutants by phage display 173
Recognition of CMV pp65 protein antigen by human CD4 T cell lines induced with an immunodominant peptide pool 171
Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85 171
The antimicrobial peptide M33. An example of drug development 168
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies 167
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 167
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 165
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution 165
Branched neurotensin peptides for tumor targeting 163
Tumor imaging with tetrabranched neurotensin 162
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 161
Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66 158
Dendrimeric peptides for tumor targeting 157
Synthesis and purification of site-specific peptide conjugated to bovine pancreatic trypsin inhibitor 154
NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor 153
Polipeptidi correlati alle catene pesanti delle dineine in tubetti pollinici di Nicotiana tabacum 153
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell binding site 149
Natural analogue peptides of an HIV-1 GP-120 T-helper epitope antagonize response of GP-120 specific human CD4 T-cell clones 147
A strategy for isolation af catalytic activities from repertoires of enzymes displayed on phage 147
New Developments in Heterocyclic Silyl Enol Ether Chemistry: Synthesis and Lewis Acid Mediated Reactions with Carbon Electrophiles of 2,5-bis(trimethylsiloxy)thiophene and 1-Methyl-2,5-bis(trimethylsiloxy)pyrrole 144
Histidyl tags and structural stabilization of linear peptides 142
Synthetic peptides in the form of dendrimers can become resistant to protease activity 141
Resolution of Conformational Equilibria In Linear Peptides By Circular-dichroism In Cryogenic Solvents 141
Synthetic inhibitors of anthrax lethal toxin 139
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 138
Recognition of human T-leukaemia virus (HTLV-1) envelope by human CD4+ - cell lines from HTLV-1 seronegative individuals: Specificity and clonal heterogeneity 133
NMR studies of the interaction of alpha-bungarotoxin with a mimotope of the nicotinic acetylcholine receptor 131
On the structural stability of a small bioactive peptide of potential use in biotechnology 127
Structurally driven selection of human hepatitis C virus mimotopes. 125
Role of manganese in MG-63 osteosarcoma cell attachment to fibrinogen and von Willabrand factor 120
Strong synthetic inhibitors of anthrax lethal toxin 120
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 112
Peptides mimotopes of the nicotinic receptor binding site 100
Totale 27.665
Categoria #
all - tutte 67.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 0 0 130
2021/20221.223 76 175 86 136 58 29 51 61 44 125 116 266
2022/20232.010 122 209 246 294 205 394 26 171 183 71 72 17
2023/20241.344 36 50 143 70 50 391 472 16 3 15 10 88
2024/20252.536 65 141 270 137 293 131 70 131 200 86 282 730
2025/202612.795 487 2.663 5.945 828 1.179 243 579 204 230 288 98 51
Totale 27.665